Dexcom balance sheet
At the end of fiscal 2025, Dexcom had total assets of $6.34bn, total liabilities of $3.59bn and shareholders' equity of $2.75bn. It held $918m in cash against $1.24bn of debt: net debt of $323m.
Balance sheet
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4 | 5 | 3 | 8 | 43 | 72 | 86 | 95 | 442 | 1,137 | 446 | 818 | 1,053 | 642 | 566 | 606 | 918 | 961 |
| Receivables | — | — | — | — | — | 42 | 74 | 102 | 134 | 227 | 286 | 429 | 514 | 713 | 974 | 1,006 | 1,216 | 1,186 |
| Inventory | — | 8 | 8 | 7 | 9 | 16 | 35 | 45 | 45 | 71 | 120 | 235 | 357 | 307 | 560 | 543 | 629 | 771 |
| Total current assets | — | 65 | 105 | 78 | 93 | 146 | 231 | 280 | 745 | 1,700 | 1,969 | 3,425 | 3,684 | 3,669 | 4,426 | 4,301 | 4,033 | 3,916 |
| Goodwill | — | — | 0 | 3 | 3 | 3 | 4 | 11 | 12 | 19 | 19 | 19 | 27 | 26 | 25 | 23 | 24 | 24 |
| Total assets | — | 77 | 121 | 106 | 123 | 185 | 292 | 403 | 904 | 1,916 | 2,395 | 4,291 | 4,933 | 5,392 | 6,265 | 6,485 | 6,340 | 6,239 |
| Deferred revenue (current) | — | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 2 | 10 | 18 | 8 | — | — |
| Total current liabilities | — | 15 | 15 | 20 | 32 | 41 | 67 | 102 | 139 | 222 | 360 | 614 | 721 | 1,839 | 1,556 | 2,932 | 2,143 | 2,253 |
| Long-term debt | — | — | — | 7 | 7 | 5 | — | 0 | 328 | 1,010 | 1,060 | 2,033 | 1,982 | 1,198 | 2,434 | 1,237 | 1,241 | 1,244 |
| Total debt | 0 | 1 | 0 | 7 | 7 | 5 | 0 | 0 | 328 | 1,010 | 1,060 | 2,033 | 1,982 | 1,970 | 2,434 | 2,441 | 1,241 | 1,244 |
| Total liabilities | — | 16 | 16 | 29 | 38 | 44 | 71 | 119 | 485 | 1,253 | 1,512 | 2,464 | 2,891 | 3,260 | 4,196 | 4,382 | 3,594 | 3,703 |
| Shareholders' equity | −18 | 61 | 105 | 77 | 84 | 140 | 221 | 284 | 419 | 663 | 883 | 1,552 | 2,042 | 2,132 | 2,069 | 2,103 | 2,746 | 2,535 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | — | — | — | — | — | — | — | — | — | 275 | — | — | — | — | — | — |
| Net debt (negative = net cash) | −4 | −4 | −3 | −1 | −36 | −67 | −86 | −95 | −114 | −127 | 614 | 1,216 | 929 | 1,328 | 1,868 | 1,835 | 323 | 282 |
| Shares outstanding | — | 248m | 270m | 278m | 290m | 309m | 327m | 338m | 348m | 360m | 366m | 384m | 388m | 386m | 385m | 391m | 385m | 373m |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 1,006 | 1,155 | 1,349 | 1,110 | 1,216 | 1,089 | 1,258 | 1,186 |
| Inventory | 543 | 538 | 571 | 604 | 629 | 694 | 726 | 771 |
| Total current assets | 4,301 | 4,554 | 5,030 | 5,220 | 4,033 | 4,332 | 4,087 | 3,916 |
| Goodwill | 23 | 23 | 24 | 24 | 24 | 24 | 24 | 24 |
| Total assets | 6,485 | 6,752 | 7,327 | 7,500 | 6,340 | 6,633 | 6,455 | 6,239 |
| Deferred revenue (current) | 8 | 8 | 6 | 3 | — | — | — | — |
| Total current liabilities | 2,932 | 3,037 | 3,309 | 3,336 | 2,143 | 2,224 | 2,358 | 2,253 |
| Long-term debt | 1,237 | 1,238 | 1,239 | 1,240 | 1,241 | 1,242 | 1,243 | 1,244 |
| Total debt | 1,237 | 1,238 | 1,239 | 1,240 | 1,241 | 1,242 | 1,243 | 1,244 |
| Total liabilities | 4,382 | 4,485 | 4,754 | 4,774 | 3,594 | 3,676 | 3,834 | 3,703 |
| Shareholders' equity | 2,103 | 2,267 | 2,573 | 2,726 | 2,746 | 2,957 | 2,621 | 2,535 |
| Shares outstanding | 391m | 392m | 392m | 390m | 385m | 386m | 377m | 373m |
Compare with peers
- Bausch & Lomb Corp balance sheet
- Idexx Laboratories balance sheet
- ResMed| balance sheet
- Steris balance sheet
- Edwards Lifesciences balance sheet
Head to head: BLCO vs DXCMDXCM vs IDXXDXCM vs RMD
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies